Known for creating the groundbreaking businesses that defined the Streaming TV sector and the Hologram Entertainment business, Alki David identified CBD as his next big enterprise, and launched Swissx Labs in 2015, with the goal of expanding and revolutionizing the the global market for safe, legal CBD products.
As CEO of Swissx Labs, Matt Bentley leads the biotech division of Swissx, providing strategic direction as the Swissx team fulfills its mission to develop innovative new legal cannabis strains used to make the world's purest, most effective CBD and CBG products.
Your use of this website indicates your understanding of the following:
The information on this website is for informational purposes only and is not intended to assess, diagnose, or treat any medical or mental health disease or condition. Use of this website does not imply nor establish any type of therapist-client relationship. This information is solely intended to educate viewers about the importance of careful, skillful preparation and integration for those who have chosen to use plant medicine. Any acknowledgements made here by the owners of this website regarding potentially beneficial and therapeutic effects of medicinal plant compounds are in no way a recommendation for their use, as plant medicines may be contraindicated for certain health and mental health conditions. Any information obtained from this website should not be considered a substitute for a thorough medical and/or mental health evaluation from an appropriately credentialed and licensed professional in your area. Please consult with such a professional to determine if plant medicine is appropriate for you. Swissx explicitly disclaims any liability, loss, injury, or damage, from the use or application of information contained on this website or from your informed decision to partake in the activities and services described herein.